Results 41 to 50 of about 140,892 (150)
Pharmacotherapy and other aspects of senior medical students’ knowledge in community-acquired pneumonia: the final results of the KNOCAP II project [PDF]
Р. А. Бонцевич +13 more
openalex +1 more source
Triple-negative breast cancer (TNBC) is among the aggressive subtype of breast cancer with a distinct lack of viable treatment strategies and poor clinical outcomes.
Mohammed O. Gbadamosi +5 more
doaj +1 more source
Clozapine (CLZ) is used for treatment‐resistant schizophrenia. However, in Japanese patients, its pharmacokinetics are still not well described, and there are no case reports about drug interactions between CLZ and concomitant antiepileptics that can ...
Kazuro Ikawa +7 more
doaj +1 more source
Introduction Organ transplant recipients face a substantial risk of developing posttransplant lymphoproliferative disorders (PTLD). In over 90% of cases with B‐cell PTLD following solid organ transplantation, the Epstein‐Barr virus (EBV) genome is ...
Marjan Moghadamnia +4 more
doaj +1 more source
Overcoming Barriers to Better Heath Outcomes in Patients with Diabetes – Improving and Balancing Patient Education and Pharmacotherapy Initiation [PDF]
Linda M. Siminerio
openalex +1 more source
Chemotherapy-induced neuropathy is a highly problematic, dose-limiting effect of potentially curative regimens of cancer chemotherapy. When neuropathic pain is severe, patients often either switch to less-effective chemotherapy agents or choose to ...
Masanobu Tsubaki +8 more
doaj +1 more source
Recent experimental data shows that hesperetin, a citrus flavonoid, affects potassium channels and can prolong the QTc interval in humans. Therefore, in the present study we investigated the effects of hesperetin on various transmembrane ionic currents ...
Aiman Saleh A. Mohammed +8 more
doaj +1 more source
Age and pharmacotherapy of suicidal depressed bipolar patients [PDF]
Maria A. Oquendo, Hanga Galfalvy
openalex +1 more source
Pharmacotherapy of the most frequent headaches in adults [PDF]
Jasna Zidverc‐Trajkovic
openalex +1 more source
Background/Objectives: Since 2023, enalapril orodispersible minitablets have been approved in Europe for paediatric heart failure from birth, but no population pharmacodynamic analyses have yet been conducted in this patient group. The objectives were to
Melina Steichert +5 more
doaj +1 more source

